This edition wraps up FY2025 M&A activity across Australian health, wellbeing and pharmaceuticals and sets out strategic perspectives for FY2026. It tracks listed-market performance, deal flow and strategic buyer activity across health, wellness, personal care and pharma.

Backed by Edison's cross-border deal experience and proprietary research, it helps founders and boards read valuation trends and position for the year ahead.

Read the full report

This report is available on request. Share a few details and we will email you a personal link to download it.

Want early access to our next report?

Register your interest and we will share our latest sector insight as it is published.